Breakthrough Therapy status – expedited FDA regulatory approval but what about the payers?
May 1, 2015, 00:00
10.1016/j.jval.2015.03.436
https://www.valueinhealthjournal.com/article/S1098-3015(15)00493-3/fulltext
Title :
Breakthrough Therapy status – expedited FDA regulatory approval but what about the payers?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00493-3&doi=10.1016/j.jval.2015.03.436
First page :
A75
Section Title :
Research Poster Presentations - Session II
Open access? :
No
Section Order :
1540